TY - JOUR
T1 - Atrial fibrillation begets heart failure and vice versa
T2 - Temporal associations and differences in preserved versus reduced ejection fraction
AU - Santhanakrishnan, Rajalakshmi
AU - Wang, Na
AU - Larson, Martin G.
AU - Magnani, Jared W.
AU - McManus, David D.
AU - Lubitz, Steven A.
AU - Ellinor, Patrick T.
AU - Cheng, Susan
AU - Vasan, Ramachandran S.
AU - Lee, Douglas S.
AU - Wang, Thomas J.
AU - Levy, Daniel
AU - Benjamin, Emelia J.
AU - Ho, Jennifer E.
N1 - Funding Information:
This work was partially supported by the National Heart, Lung and Blood Institute’s Framingham Heart Study (contracts N01-HC-25195 and HHSN268201500001I). This work was supported by the National Institutes of Health (K23-HL116780 to Dr Ho, 1R01HL128914 to Dr Benjamin, 2R01HL092577 and 3R01HL092577-06S1 to Drs Benjamin and Ellinor). Dr Ho is supported by a Boston University School of Medicine, Department of Medicine Career Investment Award (Boston, MA). Dr Lubitz is supported by National Institutes of Health/National Heart, Lung and Blood Institute K23HL114724 and Doris Duke Charitable Foundation Clinical Scientist Development Award 2014105.
Funding Information:
This work was partially supported by the National Heart, Lung and Blood Institute?s Framingham Heart Study (contracts N01-HC-25195 and HHSN268201500001I). This work was supported by the National Institutes of Health (K23-HL116780 to Dr Ho, 1R01HL128914 to Dr Benjamin, 2R01HL092577 and 3R01HL092577-06S1 to Drs Benjamin and Ellinor). Dr Ho is supported by a Boston University School of Medicine, Department of Medicine Career Investment Award (Boston, MA). Dr Lubitz is supported by National Institutes of Health/National Heart, Lung and Blood Institute K23HL114724 and Doris Duke Charitable Foundation Clinical Scientist Development Award 2014105.
Publisher Copyright:
© 2016 American Heart Association, Inc.
PY - 2016/2/2
Y1 - 2016/2/2
N2 - Background - Atrial fibrillation (AF) and heart failure (HF) frequently coexist and together confer an adverse prognosis. The association of AF with HF subtypes has not been well described. We sought to examine differences in the temporal association of AF and HF with preserved versus reduced ejection fraction. Methods and Results - We studied Framingham Heart Study participants with new-onset AF or HF between 1980 and 2012. Among 1737 individuals with new AF (mean age, 75±12 years; 48% women), more than one third (37%) had HF. Conversely, among 1166 individuals with new HF (mean age, 79±11 years; 53% women), more than half (57%) had AF. Prevalent AF was more strongly associated with incident HF with preserved ejection fraction (multivariable-adjusted hazard ratio [HR], 2.34; 95% confidence interval [CI], 1.48-3.70; no AF as referent) versus HF with reduced ejection fraction (HR, 1.32; 95% CI, 0.83-2.10), with a trend toward difference between HF subtypes (P for difference=0.06). Prevalent HF was associated with incident AF (HR, 2.18; 95% CI, 1.26-3.76; no HF as referent). The presence of both AF and HF portended greater mortality risk compared with neither condition, particularly among individuals with new HF with reduced ejection fraction and prevalent AF (HR, 2.72; 95% CI, 2.12-3.48) compared with new HF with preserved ejection fraction and prevalent AF (HR, 1.83; 95% CI, 1.41-2.37; P for difference=0.02). Conclusions - AF occurs in more than half of individuals with HF, and HF occurs in more than one third of individuals with AF. AF precedes and follows HF with both preserved and reduced ejection fraction, with some differences in temporal association and prognosis. Future studies focused on underlying mechanisms of these dual conditions are warranted.
AB - Background - Atrial fibrillation (AF) and heart failure (HF) frequently coexist and together confer an adverse prognosis. The association of AF with HF subtypes has not been well described. We sought to examine differences in the temporal association of AF and HF with preserved versus reduced ejection fraction. Methods and Results - We studied Framingham Heart Study participants with new-onset AF or HF between 1980 and 2012. Among 1737 individuals with new AF (mean age, 75±12 years; 48% women), more than one third (37%) had HF. Conversely, among 1166 individuals with new HF (mean age, 79±11 years; 53% women), more than half (57%) had AF. Prevalent AF was more strongly associated with incident HF with preserved ejection fraction (multivariable-adjusted hazard ratio [HR], 2.34; 95% confidence interval [CI], 1.48-3.70; no AF as referent) versus HF with reduced ejection fraction (HR, 1.32; 95% CI, 0.83-2.10), with a trend toward difference between HF subtypes (P for difference=0.06). Prevalent HF was associated with incident AF (HR, 2.18; 95% CI, 1.26-3.76; no HF as referent). The presence of both AF and HF portended greater mortality risk compared with neither condition, particularly among individuals with new HF with reduced ejection fraction and prevalent AF (HR, 2.72; 95% CI, 2.12-3.48) compared with new HF with preserved ejection fraction and prevalent AF (HR, 1.83; 95% CI, 1.41-2.37; P for difference=0.02). Conclusions - AF occurs in more than half of individuals with HF, and HF occurs in more than one third of individuals with AF. AF precedes and follows HF with both preserved and reduced ejection fraction, with some differences in temporal association and prognosis. Future studies focused on underlying mechanisms of these dual conditions are warranted.
KW - atrial fibrillation
KW - epidemiology
KW - heart failure
KW - mortality
KW - ventricular function, left
UR - http://www.scopus.com/inward/record.url?scp=84956824866&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84956824866&partnerID=8YFLogxK
U2 - 10.1161/CIRCULATIONAHA.115.018614
DO - 10.1161/CIRCULATIONAHA.115.018614
M3 - Article
C2 - 26746177
AN - SCOPUS:84956824866
SN - 0009-7322
VL - 133
SP - 484
EP - 492
JO - Circulation
JF - Circulation
IS - 5
ER -